Balance Sheet Components

3 Months Ended

Mar. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Note 3—Balance Sheet Components

Prepaid expenses and other current assets consisted of the following (in thousands):

	March 31, 2021		December 31, 2020
Prepaid research and development	$	6,281	$	2,462
Prepaid insurance		1,654		2,480
Prepaid bonus		1,115		409
Prepaid clinical trial		928		944
Other		839		331
Total prepaid expenses and other current assets	$	10,817	$	6,626

Property, plant and equipment consisted of the following (in thousands):

	March 31, 2021			December 31, 2020
Computer equipment	$	242		$	95
Laboratory equipment		407			—
Construction in progress		1,889			201
		2,538			296
Accumulated depreciation		(41	)		(9	)
Property, plant and equipment, net	$	2,497		$	287

Depreciation expense was $32,000 for the three months ended March 31, 2021. There was no depreciation expense for the three months ended March 31, 2020.

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31, 2021		December 31, 2020
Accrued research and development	$	5,672	$	2,106
Accrued license fees		5,500		—
Accrued compensation		1,427		1,766
Accrued professional and consulting fees		1,119		999
Accrued construction in progress		1,029		173
Other		128		91
Total accrued expenses and other current liabilities	$	14,875	$	5,135